NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
FAQ: 2025 BioUtah Life Sciences Awards at the Mayer Brown Utah Life Sciences Summit
TL;DR
BioUtah's 2025 Life Sciences Awards showcase innovators whose breakthroughs like HIV drug development and cancer therapies create significant market advantages for Utah's life sciences industry.
BioUtah presents five awards at its November 12 summit recognizing leaders based on criteria including research impact, patent development, company growth, and ecosystem building contributions.
These award winners are developing transformative healthcare solutions including HIV prevention drugs and precise cancer therapies that improve patient outcomes worldwide.
Wesley Sundquist's HIV research led to FDA-approved Lenacapavir while Nusano's platform produces 40+ isotopes for cancer treatment, showcasing Utah's scientific innovation.
Found this article helpful?
Share it with your network and spread the knowledge!
The BioUtah Life Sciences Awards recognize leaders, innovators, entrepreneurs, and companies who have made significant contributions to Utah's life sciences industry, and they will be presented on November 12, 2025, during the morning plenary session of the Mayer Brown Utah Life Sciences Summit.
The awards ceremony is taking place at the Hilton Salt Lake City Center Hotel in Salt Lake City, Utah, as part of the Mayer Brown Utah Life Sciences Summit.
Award winners include Wesley Sundquist, PhD, for his HIV research that led to FDA approval of Lenacapavir, and Fred Lampropoulos, Executive Chairman of Merit Medical Systems, for his leadership in growing the company to over $1.5 billion in revenue and expanding it globally.
These awards highlight the innovation and dedication that define Utah's life sciences community, recognizing individuals and companies whose work delivers transformative healthcare solutions to patients in Utah and worldwide.
To register for the summit and learn more about the award winners, visit utahlifesciencessummit.com.
Wesley Sundquist received his award for decades of contributions to Utah's life sciences industry, particularly his research on HIV assembly and replication that led to the FDA's approval of Lenacapavir in June 2025 for HIV prevention.
Fred Lampropoulos was recognized for founding and guiding Merit Medical Systems since 1987, resulting in over 500 patents, expanding the company globally, and growing it to over $1.5 billion in revenue through product development and strategic acquisitions.
BioUtah is organizing and presenting the awards, with leadership comments provided by Kelvyn Cullimore, President and CEO of BioUtah, and Mark Paul, Executive Director of the University of Utah Health Center for Medical Innovation and Chair of the BioUtah Board of Directors.
Curated from Reportable
